Lantern Pharma, Inc. (LTRN)
3.42
-0.09
(-2.56%)
USD |
NASDAQ |
Jan 16, 16:00
3.43
+0.01
(+0.29%)
After-Hours: 20:00
Lantern Pharma Market Cap: 38.25M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.861B |
| Palatin Technologies, Inc. | 16.31M |
| Theriva Biologics, Inc. | 6.586M |
| Oragenics, Inc. | 0.7818M |
| NanoViricides, Inc. | 21.24M |
Market Cap Related Metrics
| Price to Book Value | 3.990 |
| Price | 3.42 |
| Earnings Yield | -51.25% |